Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRIM33 | Q9UPN9 | 10/20 | 0.48 |
| ▸ | TRIM24 | O15164 | 3/20 | 0.47 |
| ▸ | AKT1 | P31749 | 1/20 | 0.47 |
| ▸ | AKT2 | P31751 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | CDK4 | P11802 | 2/20 | 0.43 |
| ▸ | CDK2 | P24941 | 2/20 | 0.43 |
| ▸ | BRD4 | O60885 | 1/20 | 0.42 |
| ▸ | ALPG | P10696 | 1/20 | 0.41 |
| ▸ | F2 | P00734 | 1/20 | 0.41 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.40 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25417063 | 0.83 | AKT1 (0.46) | TRIM33AKT1AKT2F2CYP11B1 | |
| SCHEMBL25415556 | 0.74 | HSD17B10 (0.42) | MAPTF2 | |
| SCHEMBL25416724 | 0.74 | AKT1 (0.51) | TRIM33AKT1AKT2NPC1MAPT | |
| SCHEMBL25415154 | 0.73 | NPC1 (0.53) | NPC1MAPTRAB9ABRD4 | |
| SCHEMBL2127536 | 0.70 | AKT1 (0.58) | TRIM33TRIM24AKT1AKT2NPC1 | |
| SCHEMBL25416172 | 0.70 | AKT1 (0.45) | AKT1AKT2MAPT | |
| SCHEMBL7466484 | 0.69 | AKT1 (0.60) | AKT1AKT2NPC1MAPTRAB9A | |
| SCHEMBL3500174 | 0.69 | SLC2A1 (0.50) | TRIM33AKT1AKT2MAPTBRD4 | |
| SCHEMBL26931747 | 0.69 | BRD4 (0.51) | TRIM33TRIM24AKT1AKT2NPC1 | |
| SCHEMBL11263888 | 0.69 | ALPG (0.82) | TRIM33TRIM24ALPG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260071117-A1 | FUNABLE FLUORESCENT COMPOUNDS AND USES THEREOF | UNIV ARIZONA (US) | 2026-03-12 | — | — | US | disclosed |
| WO-2023081261-A1 | TUNABLE FLUORESCENT COMPOUNDS AND USES THEREOF | ARIZONA BOARD OF REGENTS ON BEHALF OF THE UNIVERSITY OF ARIZONA (US) | 2023-05-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260071117-A1 | FUNABLE FLUORESCENT COMPOUNDS AND USES THEREOF | H1-3, NISCH, H1-2 | TRIM33 3976/4885TRIM24 2239/4885AKT1 3389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.